New Release of NCCN Guidelines for Patients: Colon Cancer; Updated NCCN Guidelines for Patients: Prostate Cancer

New NCCN Guidelines for Patients: Colon Cancer and Updated NCCN Guidelines for Patients: Prostate Cancer are now available on-line at NCCN.com. The same authoritative source referenced by physicians and other health care professionals is now written for and available to patients and their caregivers.

FORT WASHINGTON, Pa.--(BUSINESS WIRE)-- In order to provide people with cancer and their caregivers state-of-the-art treatment information in patient-friendly language, the National Comprehensive Cancer Network® (NCCN®) has developed two new publications: a new release of the NCCN Guidelines for Patients: Colon Cancer and an update to the NCCN Guidelines for Patients: Prostate Cancer. The guidelines provide a framework to help people with cancer talk with their physician about the best treatment options.

According to the 2012 annual report from the American Cancer Society (ACS), the Centers for Disease Control and Prevention (CDC), the National Cancer Institute (NCI), and the North American Association of Central Cancer Registries (NAACCR) (Seigel, Naishadham, & Jemal, 2012), colon cancer is the fourth most common cancer in the United States. The newly released NCCN Guidelines for Patients: Colon Cancer include a treatment guide covering the different stages of colon cancer from early detection and diagnosis throughout treatment, across the entire continuum of care. The guidelines describe tests and treatment options for colon cancer, along with treatment side effects. A thorough glossary is included to aid patients with medical terminology. These guidelines suggest the best practice for colon cancer care and support enrollment into clinical trials when appropriate.

Prostate cancer is a complex disease; fortunately there is a dearth of sound data to support treatment recommendations. NCCN’s Guidelines for Patients: Prostate Cancer cover several variables (including life expectancy, disease characteristics, predicted outcomes, and patient preferences) that should be considered by the patient and the physician in tailoring prostate cancer therapy to the individual patient. The guidelines provide information that will help people with prostate cancer and their friends and family understand the cancer, and further to help them talk with their cancer care team about the best treatment options. In particular, the guidelines give treatment recommendations based on the characteristics of the cancer possible side effects of treatments, and a side-by-side comparison of the main benefits and disadvantages of the treatments for prostate cancer.

The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) are the most widely used guidelines in oncology practice; physicians around the globe use the NCCN Guidelines when determining appropriate cancer treatment for their patients. The NCCN Guidelines for Patients present the same information that physicians use when making treatment decisions for people with cancer, and provide it in an easy-to-understand format.

The NCCN Guidelines for Patients: Colon Cancer and Prostate Cancer are available free of charge on-line at NCCN.com and NCCN.org. The updated NCCN Guidelines for Patients: Prostate Cancer is also available in print booklet format. To request a hard copy of this resource, e-mail [email protected].

Through the support of the NCCN Foundation, NCCN now offers a library of nine NCCN Guidelines for Patients, including those on breast, colon, ovarian, non-small cell lung and prostate cancers, as well as chronic myelogenous leukemia, malignant pleural mesothelioma, melanoma, and multiple myeloma. All of these Guidelines are available free of charge at NCCN.com, which also features informative articles for patients and caregivers. These guidelines are also featured on NCCN.org.

About the National Comprehensive Cancer Network

The National Comprehensive Cancer Network® (NCCN®), a not-for-profit alliance of 21 of the world’s leading cancer centers, is dedicated to improving the quality and effectiveness of care provided to patients with cancer. Through the leadership and expertise of clinical professionals at NCCN Member Institutions, NCCN develops resources that present valuable information to the numerous stakeholders in the health care delivery system. As the arbiter of high-quality cancer care, NCCN promotes the importance of continuous quality improvement and recognizes the significance of creating clinical practice guidelines appropriate for use by patients, clinicians, and other health care decision-makers. The primary goal of all NCCN initiatives is to improve the quality, effectiveness, and efficiency of oncology practice so patients can live better lives.

The NCCN Member Institutions are: City of Hope Comprehensive Cancer Center, Los Angeles, CA; Dana-Farber/Brigham and Women’s Cancer Center | Massachusetts General Hospital Cancer Center, Boston, MA; Duke Cancer Institute, Durham, NC; Fox Chase Cancer Center, Philadelphia, PA; Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT; Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance, Seattle, WA; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD; Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL; Memorial Sloan-Kettering Cancer Center, New York, NY; H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL; The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute, Columbus, OH; Roswell Park Cancer Institute, Buffalo, NY; Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine, St. Louis, MO; St. Jude Children’s Research Hospital/University of Tennessee Cancer Institute, Memphis, TN; Stanford Comprehensive Cancer Center, Stanford, CA; University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, AL; UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; University of Michigan Comprehensive Cancer Center, Ann Arbor, MI; UNMC Eppley Cancer Center at The Nebraska Medical Center, Omaha, NE; The University of Texas MD Anderson Cancer Center, Houston, TX; and Vanderbilt-Ingram Cancer Center, Nashville, TN.

Clinicians, visit NCCN.org. Patients and caregivers, visit NCCN.com.

NCCN aims to provide people with cancer and the general public state-of-the- art cancer treatment information in easy-to-understand language. The NCCN Guidelines for Patients™, translations of the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®), are meant to help patients with cancer talk with their physician about the best treatment options. These guidelines do not replace the expertise and clinical judgment of the physician.



CONTACT:

National Comprehensive Cancer Network (NCCN)
Mary Buemi, 215-690-0576
[email protected]

KEYWORDS:   United States  North America  Pennsylvania

INDUSTRY KEYWORDS:   Other Consumer  Health  Public Policy/Government  Healthcare Reform  Oncology  Public Policy  Communications  Publishing  Consumer  Managed Care

MEDIA:

Logo
 Logo

Suggested Articles

The profit margins and management of Community Health Group raise questions about oversight of managed care insurers.

Financial experts are warning practices about the pitfalls of promoting medical credit cards to their patients.

A proposed rule issued by HHS on Tuesday would expand short-term coverage, a move Seema Verma said will have "virtually no impact" on ACA premiums.